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values of NMP22do not requlre adjustment using other substances such as urinary
creatinine．On the other hand，its values might vary according to urine concentration．
This studyinvestigated theintra－day variationin the urinarylevelof NMP22．NMP22




and spot samplesin all patients．Out oflO bladder cancer patients，6had positive
24－hour samples．Among these6patients，Only3had4positive spot samples（＞12．O
U／ml）：Onehad3positivesamples，and2hadonepositivesample．AmongthecontroIs，
Onlyonepatientwithrenalcancerhadapositive24110urSample．Only3controIs，2With
prostatic cancer and one with renalcancer，had a single positive spot sample・The




urinary creatinine　む＝0．575，p＜0．001）．The urinarylevel of NMP22showsintra－day
variationandmightbeaffectedbytheextentoftheconcentrationofurinesamples・The
measurement results must be judged with thisin mind，eSpeCially when judging the











NMP22is a component of nuclear mitotic apparatus帥uMA）protein，Which becomes
solubleandisreleasedintotheurinefromthenucleusaftercelldeath．NMP22isrecognized
by2monoclonalantibodies，MAb302－22andMAb302－18，Whichwereraisedagainstnuclear








this study．The subjects consisted oflO patients with untreated bladder cancer，5with
nonlurOthelialcancer，and5withbenignurogenitaltumors，Whorangedfrom58to76years
oldwithameanageof65．4years．AmongthelObladdercancerpatients，Onehadbladder
tumOrS that developed after a complete nephro－uretereCtOmy for ureteralcancer・The five
patients with non－urOthelialcancer consisted of3with renalcancer and2with prostatic
cancer．Thefivepatientswithbenignurogenitaltumorsconsistedof3Withbenignprostatic
hyperplasia，One Withrenalangiomyolipoma，and onewith a benign adrenaltumor・Serum
creatininewaswithinourstandardrangeの．8to1．1mg／dl）in allsubjects．Al110bladder
canCerpatientswerehistologicallyconfirmedtohavetransitionalcellcarcinoma：Sixpatients





The collection of urine samples was performed during hospitalization before surgical
treatment．Subjectswerenotonintravenoustherapyduring24110urCOllectionandtheyhad
nolimitations on diet orwaterintake．Four voidedurine sampleswere collectedintopaper
cupsat6a．m．亀sting），10a．m．CZhoursafterbreakfast），2p．m．短hoursafterlunchland9
p．m．短hours after dinner）．Each sample was promptly transferredinto specialtubes for
measurementofNMP22andurinarycreatinineh｛r）6mleach），andtherestwascollected
into a24－hour urine sample bottle．The24－hour samples were stirred after measurlng
volume．These5sampleskspotsamplesandone24－hoursample）wereusedformeasuring
NMP22and ulニr．Allthe samples were keptin a refrigerator at4℃untilmeasurement．
Collection of24－hour urine samples was started at2p．m．after voiding and was finished
withvoidingat2p．m．onthefollowingday．Thenthefirstspotsamplewastakenat9p・m・
and the finalonewas at2p．m．NMP22was measuredwith a Matritech UNMP22test kit
Q（onica，Tokyo，Japan），andul：rwasmeasuredbythealkalinepicratemethod．
Theobjectivesandmethodswereexplainedandinformedconsentwasobtainedfromall
the subjects．The kitsfor NMP22were obtained from Konica・NMP22and u－tr were
Intra－dayvariationofurinaryNMP22 （183）
measuredbySRL（rokyo，Japan）．
For statistical analysis，the x2test and McNear，s test were used forinter－grOup
COmparisons，WhileSpearman’srankcorrelationandtheMannlVhitneyU－teStWereuSedfor
assessing correlations．Calculations were doneusing StatView software kersion5．0，SAS
Inc．，Cary，NC，USA）．ThestandardvalueofNMP22employedinthisstudywas12．OU／ml．
Thefollowinganalysesweredonebyjudgingsampleswithmorethan12．1U／mlaspositive








































































































































































































































































































slgnificant differences between the mean valuesfor the bladder cancer patients and the
























Collection times，yielding the maximumand minimum NMP221evels：The sample
collectiontimethatyieldedthemaximumNMP221evelineachpatientwasanalyzed・Outof












wereless than2U／ml）to16．6U／ml，With amean of5．1±5．5U／mland a median of3，2
U／ml．
Correlation between NMP22and u－Cr：Because there was a possibility that NMP22
values were affected by urine volume or concentration，the correlation between NMP22


















NMP22not only shows a highsensitivity as a screening method for urothelialcancers
butalsoalowfalsellegativeratecomparedtourinarycytologythatdependsontheskillof
the examiner．NMP221evels were significantly higherin bladder cancer patients thanin
COntrOIs for both the24－hourand spot samples，SuggeSting the usefulness of NMP22as a
SCreeningmethod．
Since cell cycle acceleration would resultin an elevated NMP221evel，urinary tract
infection and mechanical　stimulation of the urothelium such as catheterization or
transurethralsurgerymight cause falsel）OSitive results．Moreover，itwas reported that the
NMP22　Value was affected by hematuria，15）while Chen et al．14）mentioned that urine
COllection should be done between midnight and noon．Thus，NMP22values may vary
accordingto the conditions ofurinesampling．Thepresentstudyexcludedpatientswithan
indwellingcatheter，Surgicaltreatment，Or Obvious urinary tractinfection，but the variation
Of NMP22values was still observed depending on the sampling time，With the highest
margins of237．8U／mlin the bladder cancer patients and16．6U／mlin the controIs．In
addition，3bladder cancerpatients and3controIs showed theintra－day changeS OfNMP22
that crossed the cutl）ffvalue．
Because the NMP221evelis not affected by renalfunction，adjustmentuslng Other
Substancessuchasu－｛rmaynotberequired．Thereisapossibility，however，thatthevalue
Can be affected by concentration of the urine，e．g．，aSSumlng that NMP22is released






betweenNMP22andulニrwas thenanalyzed，because creatinineis constantlyexcretedinto
the urine andis commonly employed for adjusting theurinarylevelofglomerular－filtered
substances．There was a slgnificant correlation between the changes of NMP22and u－｛r
whentheratioofeachspotsampletothe24－hourvaluewasassessedineachsubject・Thus，
biggerchangesofu一℃rledtolargerchangesofNMP22．Althoughthesedatadonotreduce
the clinicalusefulness ofNMP22，One must keeplnmind that water or foodintake during




NMP22were strongly correlatedwith those ofu－｛r，SuggeStingthat the NMP221evelwas
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